Loading...

Jesse Lee Berry, MD

Title(s)Associate Professor of Ophthalmology (Clinical Scholar)
Address
Phone+1 323 442 6578
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard UniversityBA2004
    Harvard Medical SchoolMD2008
    USC Roski Eye InstituteOphthalmology Residency2012
    Children's Hospital Los AngelesOcular Oncology Fellowship2014
    Collapse Awards and Honors
    2000  - 2004Harvard College Scholarship: Elizabeth Cary Agassiz Scholar
    2000  - 2004Malcolm Kinsberg Scholarship
    2002Kappa Alpha Theta Foundation Scholarship
    2003David Rockefeller Center of Latin American Studies Grant
    2004  - 2008Nevil & Louise Ford Scholarship Fund
    2005Harvard Medical International Initiatives in Research Grant
    2007Center for Eye Research and Education McCleary Grant
    2011Doheny Eye Institute Medical Knowledge Award
    2012Starr Schulman Fellowship
    2012Department of Health Services Innovation Grant
    2013Society of Heed Fellows
    2013  - 2014University of Southern California Excellence in Resident Teaching Award

    Collapse Overview 
    Collapse Overview
    Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Jonathan Kim and A. Linn Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

    Evaluation of the aqueous humor for tumor-derived genetic information and its application to prognosis and precision medicine for retinoblastoma patients. Investigating new methods of chemotherapy delivery for the treatment of Retinoblastoma. Evaluating treatment outcomes for Retinoblastoma eyes. This includes evaluation of treatment outcomes after systemic chemotherapy and the elucidation of factors present at diagnosis, which contribute to final visual outcome in eyes treated for retinoblastoma.

    Collapse Research 
    Collapse Research Activities and Funding
    Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.
    NIH/NCI K08CA232344Aug 1, 2018 - Jul 31, 2023
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic Genet. 2020 Aug 17; 1-7. Xu L, Shen L, Polski A, Prabakar RK, Shah R, Jubran R, Kim JW, Biegel J, Kuhn P, Cobrinik D, Hicks J, Gai X, Berry JL. PMID: 32799607.
      View in: PubMed   Mentions:    Fields:    
    2. Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Mol Cancer Res. 2020 Aug; 18(8):1166-1175. Xu L, Polski A, Prabakar RK, Reid MW, Chevez-Barrios P, Jubran R, Kim JW, Kuhn P, Cobrinik D, Hicks J, Berry JL. PMID: 32434859.
      View in: PubMed   Mentions: 1     Fields:    
    3. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes Chromosomes Cancer. 2020 May 11. Polski A, Xu L, Prabakar RK, Gai X, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Hicks J, Berry JL. PMID: 32390242.
      View in: PubMed   Mentions: 1     Fields:    
    4. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol. 2020 May 01; 6(5):685-695. Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A, Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaly U, Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R, Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H, Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam J, Calderón-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G, Castillo L, Català-Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B, Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM, Correa Llano MG, Corson TW, Cowan-Lyn KE, Csóka M, Cui X, Da Gama IV, Dangboon W, Das A, Das S, Davanzo JM, Davidson A, De Potter P, Delgado KQ, Demirci H, Desjardins L, Diaz Coronado RY, Dimaras H, Dodgshun AJ, Donaldson C, Donato Macedo CR, Dragomir MD, Du Y, Du Bruyn M, Edison KS, Eka Sutyawan IW, El Kettani A, Elbahi AM, Elder JE, Elgalaly D, Elhaddad AM, Elhassan MMA, Elzembely MM, Essuman VA, Evina TGA, Fadoo Z, Fandiño AC, Faranoush M, Fasina O, Fernández DDPG, Fernández-Teijeiro A, Foster A, Frenkel S, Fu LD, Fuentes-Alabi SL, Gallie BL, Gandiwa M, Garcia JL, García Aldana D, Gassant PY, Geel JA, Ghassemi F, Girón AV, Gizachew Z, Goenz MA, Gold AS, Goldberg-Lavid M, Gole GA, Gomel N, Gonzalez E, Gonzalez Perez G, González-Rodríguez L, Garcia Pacheco HN, Graells J, Green L, Gregersen PA, Grigorovski NDAK, Guedenon KM, Gunasekera DS, Gündüz AK, Gupta H, Gupta S, Hadjistilianou T, Hamel P, Hamid SA, Hamzah N, Hansen ED, Harbour JW, Hartnett ME, Hasanreisoglu M, Hassan S, Hassan S, Hederova S, Hernandez J, Hernandez LMC, Hessissen L, Hordofa DF, Huang LC, Hubbard GB, Hummlen M, Husakova K, Hussein Al-Janabi AN, Ida R, Ilic VR, Jairaj V, Jeeva I, Jenkinson H, Ji X, Jo DH, Johnson KP, Johnson WJ, Jones MM, Kabesha TBA, Kabore RL, Kaliki S, Kalinaki A, Kantar M, Kao LY, Kardava T, Kebudi R, Kepak T, Keren-Froim N, Khan ZJ, Khaqan HA, Khauv P, Kheir WJ, Khetan V, Khodabande A, Khotenashvili Z, Kim JW, Kim JH, Kiratli H, Kivelä TT, Klett A, Komba Palet JEK, Krivaitiene D, Kruger M, Kulvichit K, Kuntorini MW, Kyara A, Lachmann ES, Lam CPS, Lam GC, Larson SA, Latinovic S, Laurenti KD, Le BHA, Lecuona K, Leverant AA, Li C, Limbu B, Long QB, López JP, Lukamba RM, Lumbroso L, Luna-Fineman S, Lutfi D, Lysytsia L, Magrath GN, Mahajan A, Majeed AR, Maka E, Makan M, Makimbetov EK, Manda C, Martín Begue N, Mason L, Mason JO, Matende IO, Materin M, Mattosinho CCDS, Matua M, Mayet I, Mbumba FB, McKenzie JD, Medina-Sanson A, Mehrvar A, Mengesha AA, Menon V, Mercado GJVD, Mets MB, Midena E, Mishra DKC, Mndeme FG, Mohamedani AA, Mohammad MT, Moll AC, Montero MM, Morales RA, Moreira C, Mruthyunjaya P, Msina MS, Msukwa G, Mudaliar SS, Muma KI, Munier FL, Murgoi G, Murray TG, Musa KO, Mushtaq A, Mustak H, Muyen OM, Naidu G, Nair AG, Naumenko L, Ndoye Roth PA, Nency YM, Neroev V, Ngo H, Nieves RM, Nikitovic M, Nkanga ED, Nkumbe H, Nuruddin M, Nyaywa M, Obono-Obiang G, Oguego NC, Olechowski A, Oliver SCN, Osei-Bonsu P, Ossandon D, Paez-Escamilla MA, Pagarra H, Painter SL, Paintsil V, Paiva L, Pal BP, Palanivelu MS, Papyan R, Parrozzani R, Parulekar M, Pascual Morales CR, Paton KE, Pawinska-Wasikowska K, Pe'er J, Peña A, Peric S, Pham CTM, Philbert R, Plager DA, Pochop P, Polania RA, Polyakov VG, Pompe MT, Pons JJ, Prat D, Prom V, Purwanto I, Qadir AO, Qayyum S, Qian J, et al. PMID: 32105305.
      View in: PubMed   Mentions: 2     Fields:    
    5. Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma. Int Ophthalmol Clin. 2020; 60(2):77-89. Lu JE, Chang JR, Berry JL, In GK, Zhang-Nunes S. PMID: 32205655.
      View in: PubMed   Mentions:    Fields:    
    6. Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Genes (Basel). 2019 12 11; 10(12). Gudiseva HV, Berry JL, Polski A, Tummina SJ, O'Brien JM. PMID: 31835688.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene. Genes (Basel). 2019 11 01; 10(11). Berry JL, Polski A, Cavenee WK, Dryja TP, Murphree AL, Gallie BL. PMID: 31683923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Aqueous Humor Is Superior to Blood as a Liquid Biopsy for Retinoblastoma. Ophthalmology. 2020 04; 127(4):552-554. Berry JL, Xu L, Polski A, Jubran R, Kuhn P, Kim JW, Hicks J. PMID: 31767439.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Tumour size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features. Acta Ophthalmol. 2020 Feb; 98(1):e121-e125. Kim JW, Shah SN, Green S, O'Fee J, Tamrazi B, Berry JL. PMID: 31421017.
      View in: PubMed   Mentions:    Fields:    
    10. Evaluation of an Intervention to Reduce Low-Value Preoperative Care for Patients Undergoing Cataract Surgery at a Safety-Net Health System. JAMA Intern Med. 2019 05 01; 179(5):648-657. Mafi JN, Godoy-Travieso P, Wei E, Anders M, Amaya R, Carrillo CA, Berry JL, Sarff L, Daskivich L, Vangala S, Ladapo J, Keeler E, Damberg CL, Sarkisian C. PMID: 30907922.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Aqueous Humor Markers in Retinoblastoma, a Review. Transl Vis Sci Technol. 2019 Apr; 8(2):13. Ghiam BK, Xu L, Berry JL. PMID: 31019846.
      View in: PubMed   Mentions:
    12. A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines. Int Ophthalmol Clin. 2019; 59(2):65-75. Berry JL, Kogachi K, Murphree AL, Jubran R, Kim JW. PMID: 30908280.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. An Intraocular Pressure Predictive of High-risk Histopathologic Features in Group E Retinoblastoma Eyes. Int Ophthalmol Clin. 2019; 59(2):77-86. Kim ME, Shah S, Zolfaghari E, Jubran R, Reid MW, Kim JW, Berry JL. PMID: 30908281.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1143-1150. Nguyen SM, Sison J, Jones M, Berry JL, Kim JW, Murphree AL, Salinas V, Olch AJ, Chang EL, Wong KK. PMID: 30537543.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia. Clin Exp Ophthalmol. 2019 03; 47(2):193-200. Polski A, Sibug Saber M, Kim JW, Berry JL. PMID: 30156057.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Posterior Vitreous Detachment and the Associated Risk of Retinal Toxicity with Intravitreal Melphalan Treatment for Retinoblastoma. Ocul Oncol Pathol. 2019 Jun; 5(4):238-244. Berry JL, Lee R, Patel L, Le BHA, O'Fee J, Jubran R, Kim JW. PMID: 31367584.
      View in: PubMed   Mentions:
    17. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017. Br J Ophthalmol. 2019 09; 103(9):1272-1277. Lu JE, Francis JH, Dunkel IJ, Shields CL, Yu MD, Berry JL, Kogachi K, Skalet AH, Miller AK, Santapuram PR, Daniels AB, Abramson DH. PMID: 30361279.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Changes in Retinal Thickness on OCT from Intravitreal Melphalan. Ophthalmol Retina. 2019 03; 3(3):288-289. Narala R, Kim JW, Lang P, Le BHA, Hendargo HC, Branco D, Berry JL. PMID: 31014710.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Conjunctival Squamous Neoplasia: Staging and Initial Treatment. Cornea. 2018 Oct; 37(10):1287-1291. Bellerive C, Berry JL, Polski A, Singh AD. PMID: 29863543.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Lurking below: massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma. Ophthalmic Genet. 2018 10; 39(5):653-657. Kogachi K, Kim JW, Green S, Jubran R, Berry JL. PMID: 30142285.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review. Brachytherapy. 2018 Nov - Dec; 17(6):981-989. Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL. PMID: 30082188.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    22. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Mol Cancer Res. 2018 11; 16(11):1701-1712. Berry JL, Xu L, Kooi I, Murphree AL, Prabakar RK, Reid M, Stachelek K, Le BHA, Welter L, Reiser BJ, Chévez-Barrios P, Jubran R, Lee TC, Kim JW, Kuhn P, Cobrinik D, Hicks J. PMID: 30061186.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Integrated Treatment during the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic Chemoreduction. Ocul Oncol Pathol. 2018 Nov; 4(6):335-340. Berry JL, Shah S, Kim F, Jubran R, Kim JW. PMID: 30574483.
      View in: PubMed   Mentions:
    24. Trends in Radiation Practices for Female Ocular Oncologists in North America: A Collaborative Study of the International Society of Ocular Oncology. Ocul Oncol Pathol. 2019 Jan; 5(1):54-59. Shah SN, Kogachi K, Correa ZM, Schefler AC, Aronow ME, Callejo SA, Cebulla CM, Day-Ghafoori S, Francis JH, Lally S, McCannel TA, Paton KE, Phan IT, Pointdujour-Lim R, Ramasubramanian A, Rath P, Shields CL, Skalet AH, Wells JR, Jennelle RL, Berry JL. PMID: 30675478.
      View in: PubMed   Mentions:
    25. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma-Reply. JAMA Ophthalmol. 2018 05 01; 136(5):598. Berry JL, Cobrinik D, Hicks J. PMID: 29566117.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Iris Hypoplasia as the Presenting Sign of Retinoblastoma in a Child With a 13q Deletion. J Pediatr Ophthalmol Strabismus. 2018 Apr 23; 55:e10-e13. Shah S, Koban Y, Le BHA, Bechtold M, Zolfaghari E, Kim JW, Berry JL. PMID: 29684226.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    27. Porous orbital implant after enucleation in retinoblastoma patients: indications and complications. Orbit. 2018 Dec; 37(6):438-443. Lang P, Kim JW, McGovern K, Reid MW, Subramanian K, Murphree AL, Berry JL. PMID: 29461921.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing. Ophthalmic Genet. 2018 06; 39(3):407-409. Berry JL, Lewis L, Zolfaghari E, Green S, Le BHA, Lee TC, Murphree AL, Kim JW, Jubran R. PMID: 29286867.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Late Apical Recurrence of Choroidal Melanoma 10 Years after Successful Treatment with Brachytherapy. Ocul Oncol Pathol. 2018 Jun; 4(4):225-229. Shih GC, Le BHA, Correa ZM, Sibug-Saber ME, Kim JW, Berry JL. PMID: 30643766.
      View in: PubMed   Mentions:
    30. Loss of fundus view as an indication for secondary enucleation in retinoblastoma. Pediatr Blood Cancer. 2018 04; 65(4). Berry JL, Kogachi K, Jubran R, Kim JW. PMID: 29218818.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Risk of Extraocular Extension in Eyes With Retinoblastoma Receiving Intravitreous Chemotherapy. JAMA Ophthalmol. 2017 12 01; 135(12):1426-1429. Francis JH, Abramson DH, Ji X, Shields CL, Teixeira LF, Schefler AC, Cassoux N, Hadjistilianou D, Berry JL, Frenkel S, Munier FL. PMID: 29098285.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma. JAMA Ophthalmol. 2017 11 01; 135(11):1221-1230. Berry JL, Xu L, Murphree AL, Krishnan S, Stachelek K, Zolfaghari E, McGovern K, Lee TC, Carlsson A, Kuhn P, Kim JW, Cobrinik D, Hicks J. PMID: 29049475.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft. Graefes Arch Clin Exp Ophthalmol. 2017 Dec; 255(12):2363-2373. Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry JL, Lee DK, Rico G, Madi I, Rao N, Stachelek K, Wang LC, Gomer C. PMID: 28971251.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    34. Three presentations of CNS disease in patients with intraocular retinoblastoma at a tertiary medical center in the United States. Ophthalmic Genet. 2018 Jan-Feb; 39(1):115-119. Kim JW, Jacobsen BH, Ko M, Lee DK, Jubran RF, Berry JL. PMID: 28949779.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Atypical Retinal Pigment Epithelial Hyperplasia and Glial Proliferation Masquerading as Progressive Recurrent Retinoblastoma: A Case Report Review and Clinicopathologic Correlation. Ocul Oncol Pathol. 2018 Sep; 4(2):116-121. Zolfaghari E, Kim JW, Krishnan S, Chévez-Barrios P, Berry JL. PMID: 30320092.
      View in: PubMed   Mentions:
    36. Optical Coherence Tomography Imaging of a Large Spherical Seed in Retinoblastoma. Ophthalmology. 2017 08; 124(8):1208. Berry JL, Anulao K, Kim JW. PMID: 28734334.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Unilateral Multifocal Choroidal Melanoma. Ocul Oncol Pathol. 2017 Dec; 4(1):48-51. Mustafi D, Damato B, Berry JL. PMID: 29344499.
      View in: PubMed   Mentions:
    38. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era. Pediatr Blood Cancer. 2017 Dec; 64(12). Berry JL, Shah S, Bechtold M, Zolfaghari E, Jubran R, Kim JW. PMID: 28646513.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    39. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 2017 12; 124(12):1817-1825. Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. PMID: 28655537.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    40. Clinical Significance of Optic Nerve Enhancement on Magnetic Resonance Imaging in Enucleated Retinoblastoma Patients. Ophthalmol Retina. 2017 Sep - Oct; 1(5):369-374. Kim JW, Madi I, Lee R, Zolfaghari E, Jubran R, Lee TC, Murphree AL, Berry JL. PMID: 31047563.
      View in: PubMed   Mentions:    Fields:    
    41. Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma. Ophthalmol Retina. 2017 Sep - Oct; 1(5):361-368. Kim JW, Aziz HA, McGovern K, Zolfaghari E, Jubran RF, Murphree AL, Berry JL. PMID: 31047562.
      View in: PubMed   Mentions:    Fields:    
    42. Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion? Ocul Oncol Pathol. 2017 Nov; 3(4):283-291. Berry JL, Zolfaghari E, Chen A, Murphree AL, Jubran R, Kim JW. PMID: 29344482.
      View in: PubMed   Mentions:
    43. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan 12; 135(1):e164656. Wong BJ, Berry JL. PMID: 28030719.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 04; 64(4). Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. PMID: 28221729.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan; 3(1):34-40. Aziz HA, Kim JW, Munier FL, Berry JL. PMID: 28275601.
      View in: PubMed   Mentions:
    46. Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California. Ophthalmic Genet. 2016 12; 37(4):400-403. Berry JL, Shih G, Moysidis SN, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. PMID: 26934665.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Detection and Intraretinal Localization of an 'Invisible' Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr; 2(3):148-52. Berry JL, Cobrinik D, Kim JW. PMID: 27239455.
      View in: PubMed   Mentions:
    48. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. PMID: 27172535.
      View in: PubMed   Mentions:
    49. Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma. Ocul Oncol Pathol. 2015 Dec; 2(2):76-9. Jacobsen BH, Berry JL, Jubran R, Kim JW. PMID: 27171650.
      View in: PubMed   Mentions:
    50. Use of the Toric Surgical Marker to Aid in Intraoperative Plaque Placement for the USC Eye Physics Plaques to Treat Uveal Melanoma: A New Surgical Technique. Ophthalmic Surg Lasers Imaging Retina. 2015 Sep; 46(8):866-70. Berry JL, Kim JW, Jennelle R, Astrahan M. PMID: 26431303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015 Sep-Oct; 14(5):718-25. Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, Kampp TD, Astrahan MA, Kim JW, Berry JL. PMID: 26073224.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    52. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. Berry JL, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. PMID: 27172253.
      View in: PubMed   Mentions:
    53. Methicillin-resistant Staphylococcus aureus dacryoadenitis. JAMA Ophthalmol. 2014 Aug; 132(8):993-5. Liu W, Rootman DB, Berry JL, Hwang CJ, Goldberg RA. PMID: 24875129.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    54. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience. Br J Ophthalmol. 2014 Aug; 98(8):1061-5. Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. PMID: 24671926.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. JAMA Ophthalmol. 2013 Nov; 131(11):1435-42. Berry JL, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, Kim JW. PMID: 24008431.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013 Apr; 60(4):688-93. Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL. PMID: 22997170.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    57. Unmet need for corrective eyeglasses: results from a Los Angeles County Hospital survey. Int Ophthalmol. 2012 Jun; 32(3):245-50. Berry JL, Cuzzo LM, Bababeygy SR, Quiros PA. PMID: 22487855.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci. 2011 Jun 01; 52(6):3868-73. Lee NG, Berry JL, Lee TC, Wang AT, Honowitz S, Murphree AL, Varshney N, Hinton DR, Fawzi AA. PMID: 21273549.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    59. Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J. 2011 Jan 18; 5:1-5. Graeber CP, Gobin YP, Marr BP, Dunkel IJ, Brodie SE, Bornfeld N, Char DH, Folberg R, Imhof SM, Lin AY, Berry JL, Al Mesfer S, Moll AC, Abramson DH. PMID: 21399766.
      View in: PubMed   Mentions:
    60. Effect of saline conditions on the tensile strength of ophthalmic sutures. Ophthalmic Surg Lasers Imaging. 2011 Mar-Apr; 42(2):148-51. Brauner SC, Berry JL, Pye J, Lee EG, Rhee DJ. PMID: 21117584.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Jesse's Networks
    Concepts (207)
    Derived automatically from this person's publications.
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _